Loading…
Underlying
Underlying Price
$38.90
Type
Call
Strike
35
Expiration
Sep 17, 2027
DTE
328d
Moneyness
ITM
Intrinsic
$3.90
NVO 35 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $4.70 | +4.44% | 2 | 14 |
| Oct 30, 2026 | 6d | $4.35 | +20.83% | 2 | 103 |
| Nov 6, 2026 | 13d | $4.73 | +10.00% | 1 | 30 |
| Nov 13, 2026 | 20d | $4.95 | +34.51% | 10 | 11 |
| Nov 20, 2026 | 27d | $4.92 | +2.50% | 3 | 526 |
| Nov 27, 2026 | 34d | $4.05 | +0.00% | 4 | 4 |
| Dec 18, 2026 | 55d | $5.33 | +4.92% | 52 | 1,667 |
| Jan 15, 2027 | 83d | $5.77 | +4.91% | 50 | 8,692 |
| Mar 19, 2027 | 146d | $6.80 | +4.62% | 8 | 1,279 |
| Jun 17, 2027 | 236d | $7.49 | +4.03% | 21 | 3,176 |
| Sep 17, 2027 | 328d | $8.10 | +1.89% | 5 | 407 |
| Dec 17, 2027 | 419d | $9.05 | +4.02% | 5 | 993 |
| Jan 21, 2028 | 454d | $9.45 | +3.05% | 12 | 6,608 |
| Jun 16, 2028 | 601d | $10.00 | -4.03% | 2 | 191 |
| Dec 15, 2028 | 783d | $10.62 | -3.01% | 20 | 994 |
| Jan 19, 2029 | 818d | $11.50 | +2.04% | 4 | 889 |
NVO Nearby Strikes · Sep 17, 2027
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 20 C | $20.12 | +0.10% | 1 | 20 | ITM |
| 22.5 C | $15.65 | +1.62% | 10 | 24 | ITM |
| 25 C | $15.30 | +5.01% | 1 | 63 | ITM |
| 27.5 C | $13.45 | +4.67% | 1 | 81 | ITM |
| 30 C | $10.60 | -7.83% | 1 | 79 | ITM |
| 32.5 C | $9.75 | -2.01% | 2 | 253 | ITM |
| 35 C | $8.10 | +1.89% | 5 | 407 | ITM |
| 37.5 C | $6.85 | +5.38% | 10 | 247 | ITM |
| 40 C | $5.65 | +0.89% | 13 | 808 | OTM |
| 42.5 C | $4.57 | -0.65% | 8 | 415 | OTM |
| 45 C | $3.80 | +2.70% | 4 | 1,656 | OTM |
| 47.5 C | $3.06 | -2.86% | 2 | 1,442 | OTM |
| 50 C | $2.57 | -1.91% | 5 | 351 | OTM |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.